Company Name
FarmaSino Co., Ltd
Year of Establishment
2002
Enterprise Size
150 to 199
Annual Turnover(USD)
100,000,000 to 249,999,999
Company Introduction
FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd. is the key subsidiary of Jiangsu High Hope International Group, which is "Top 500" company in China. It is mainly engaged in R&D, manufacturing and distribution of APIs and intermediates such as Fosfomycin Trometamol, Fosfomycin Phenethylamine, Fosfomycin calcium, Fosfomycin sodium, Mildronate, L-Theanine, Diethyl iminodiacetate, N-Methylphthalimide etc.
Main Competitive Advantages
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.farmasino.com
Other Competitive Advantages
Since it was founded, FarmaSino has been approved to engage in R&D, technology transfer, import, export and domestic trade of pharmaceuticals and chemicals. Scientific and quantified Standard Operation Procedure (SOP) has been formed to fit to itself
Milestone
From a small trading company to a large comprehensive corporation, it just takes FarmaSino a few years. During these years, we experienced so many hard works, but we always believe a bright future just in the front. Supported by our friends and hard work given by our staffs, FarmaSino has grown up rapidly and steadily. We really appreciate the wisdom, diligence and passion that dedicated by every staff, which have formed health, happiness and sharing company culture.
A common purpose "Cooperation leads to bright future" brought us together, and it is also the power source of company development.
With the same aim, we meet in FarmSino, grow up with FarmaSino and expect FarmaSino to be the international reputation corporation in the near future.